key: cord-0990409-0dcbpwue
authors: Chang, Yea-Yuan; Wang, Wen-Hsiu; Ku, Stephane Wen-Wei
title: Good response of low-dose steroid in a patient with COVID-19 pneumonia and autoimmune disease
date: 2021-05-12
journal: J Microbiol Immunol Infect
DOI: 10.1016/j.jmii.2021.04.005
sha: f7ffd5c8540533b04b438866a57fac79f4a0a28c
doc_id: 990409
cord_uid: 0dcbpwue

nan

We report the case of 29-year-old Taiwanese woman with coronavirus disease (COVID-19) pneumonia with fever, anosmia, ageusia, rash, and autoimmune features, who showed a good response to short-term, low-dose steroids.

The patient had lived in California, USA, where she was diagnosed with an unspecified autoimmune disorder. On the third day of home quarantine, after returning from the USA, she developed high fever, muscle soreness, and cough (day 1). Chest radiography showed bilateral infiltrates in the lung's lower lobes, and laboratory tests revealed lymphopenia (12.9%) and monocytosis (13.9%) and were negative for influenza. Nasal swab real-time polymerase chain reaction (PCR) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed a cycle threshold value of 18 on day 3.

The patient experienced anosmia and ageusia on day 4-11, with high fever persistence despite the administration of empirical antibiotics, acetaminophen, and ibuprofen ( Fig. 1 ). On day 10, she developed a rash over both forearms and knees, with puffiness of her fingers (Supplemental Fig. 1 ). The rash was unlikely to be a drug eruption, because it disappeared briefly 7 days after stopping antibiotics and then reappeared; in total, the rash lasted 10 days. We administered a single dose of 40 mg prednisolone orally, resulting in a brief drop in temperature (Fig. 1) . The high fever J o u r n a l P r e -p r o o f recurred the next day with an episode of desaturation (oxygen saturation, 93% in room air). We started oral dexamethasone 6 mg/day on days 11-14 and tapered it to 4 mg/day on days 15-16. The fever subsided, and real-time PCR from a mouth gargle and nasal swab were weakly positive for SARS-CoV-2 (Fig. 1) .

Our patient's autoimmune profile was positive for antinuclear antibodies (ANA) 

Current status of potential therapeutic candidates for the COVID-19 crisis

A review of the dermatological manifestations of coronavirus disease 2019 (COVID-19)

The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach

Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19

We thank Shu-Chen Kuo, National Health Research Institutes, for his critical review.J o u r n a l P r e -p r o o f